Skip to content
healthcare.dev

EXTRA STRENGTH HEADACHE RELIEF

NDC 79903-044, ACETAMINOPHEN ASPIRIN CAFFEINE, tablet, coated, from WAL-MART STORES INC.

Product NDC
79903-044
Status
Listed
Labeler
WAL-MART STORES INC
Dosage form
TABLET, COATED
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M013
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/79903-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ASPIRIN250 mg/1
  • ACETAMINOPHEN250 mg/1
  • CAFFEINE65 mg/1

Pharmacologic classes

Anti-Inflammatory Agents, Non-Steroidal [CS]; Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]; Cyclooxygenase Inhibitors [MoA]; Decreased Platelet Aggregation [PE]; Decreased Prostaglandin Production [PE]; Methylxanthine [EPC]; Nonsteroidal Anti-inflammatory Drug [EPC]; Platelet Aggregation Inhibitor [EPC]; Xanthines [CS]

Package NDCNDC-11Package
79903-044-2079903004420200 TABLET, COATED in 1 BOTTLE (79903-044-20)
79903-044-42799030044421 BOTTLE in 1 CARTON (79903-044-42) / 24 TABLET, COATED in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 79903-044 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/79903-044 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 79903-044. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.